Showing results (251-260 of 331) with videos related to

Sort By:
Pageof 34
The Journal of Rheumatology. Supplement|September 3, 2014
Lifestyle interventions for the treatment of gout: a summary of 2 Cochrane systematic reviewsJohn H Y Moi, Melonie K Sriranganathan, Louise Falzon, et al.
Rheumatology Advances in Practice|February 16, 2023
Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trialsPhilip G Conaghan, Karel Pavelka, Song-Chou Hsieh, et al.
Rheumatology (Oxford, England)|September 27, 2024
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexateMaya H Buch, David Walker, Christopher J Edwards, et al.
Arthritis Care & Research|August 20, 2010
Assessment of the natural history of forefoot bursae using ultrasonography in patients with rheumatoid arthritis: a twelve-month investigationCatherine J Bowen, Lindsey Hooper, David Culliford, et al.
The Journal of Rheumatology. Supplement|September 3, 2014
Urate-lowering therapy for the management of gout: a summary of 2 Cochrane reviewsAlison S Kydd, Rakhi Seth, Rachelle Buchbinder, et al.
Annals of Emergency Medicine|July 4, 2017
Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency CareRichard C Dart, Lewis R Goldfrank, Brian L Erstad, et al.
Drugs & Aging|July 12, 2019
Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled TrialsChristopher J Edwards, Katherine Roshak, Jack F Bukowski, et al.
Rheumatology (Oxford, England)|April 11, 2018
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trialAlvin F Wells, Christopher J Edwards, Alan J Kivitz, et al.
Journal of Alzheimer'S Disease : JAD|April 26, 2024
The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic DrugCalum Marr, Bethany McDowell, Clive Holmes, et al.
Rheumatology (Oxford, England)|May 26, 2019
Lifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from EnglandEdward Burn, Christopher J Edwards, David W Murray, et al.
Pageof 34